MAL and cervical cancer: CADM1 and MAL methylation was detected in seven (63.6%) and three (27.3%) of the 11 non-metastatic cervical cancer patients (FIGO IA-IIB), respectively; nine (81.8%) patients were positive for either MAL and/or CADM1.